The lesser known side-effect of warfarin: warfarin-induced venous limb gangrene
Sheng, G.H.; Aronowitz, P.
Mayo Clinic Proceedings 89(5): E47
2014
ISSN/ISBN: 1942-5546 PMID: 24797650 DOI: 10.1016/j.mayocp.2013.05.037
Accession: 056395186
PDF emailed within 0-6 h: $19.90
Related References
Grim Hostetler, S.; Sopkovich, J.; Dean, S.; Zirwas, M. 2012: Warfarin-induced Venous Limb Gangrene Journal of Clinical and Aesthetic Dermatology 5(11): 38-42Ng, H.J.; Crowther, M.A. 2006: Malignancy-associated venous thrombosis with concurrent warfarin-induced skin necrosis, venous limb gangrene and thrombotic microangiopathy Thrombosis and Haemostasis 95(6): 1038-1039
Srinivasan, A.F.; Rice, L.; Bartholomew, J.R.; Rangaswamy, C.; La Perna, L.; Thompson, J.E.; Murphy, S.; Baker, K.R. 2004: Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia Archives of Internal Medicine 164(1): 66-70
Srinivasan, A.F.; Rice, L.; Bartholomew, J.R.; Rangaswamy, C.; La Perna, L.; Thompson, J.E.; Murphy, S.; Baker, K.R. 2004: Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia Archives of Internal Medicine 164(1): 66-70
Srinivasan, A.F.; Rice, L.; Bartholomew, J.R. 2004: Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia ACC Current Journal Review 13(4): 12-13
Warkentin, T.E.; Cook, R.J.; Sarode, R.; Sloane, D.A.; Crowther, M.A. 2015: Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome Blood 126(4): 486-493
Smythe, M.A.; Warkentin, T.E.; Stephens, J.L.; Zakalik, D.; Mattson, J.C. 2002: Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia American Journal of Hematology 71(1): 50-52
Warkentin, T.; Sarode, R.; Johnston, M.; Crowther, M. 2012: The pathogenesis of warfarin-associated venous limb ischemia and gangrene complicating cancer: clinical and laboratory parallels with heparin-induced thrombocytopenia (HIT) Thrombosis Research 129: S159-S160
Warkentin, T.E. 2001: Venous limb gangrene during warfarin treatment of cancer-associated deep venous thrombosis Annals of Internal Medicine 135(8 Pt 1): 589-593
Cojocari, V.; Casian, D.; Gutu, E. 2017: Warfarin associated venous limb gangrene in cancer-related DVT (case report) International Journal of Surgery Case Reports 32: 66-69
Gunn, S.K.; Farolino, D.; McDonald, A.A. 2009: A case of warfarin-associated venous limb gangrene: implications of anticoagulation in a palliative care setting Journal of Palliative Medicine 12(3): 269-272
Klein, L.; Galvez, A.; Klein, O.; Chediak, J. 2004: Warfarin-induced limb gangrene in the setting of lung adenocarcinoma American Journal of Hematology 76(2): 176-179
Gaikwad, T.; Ghosh, K.; Shetty, S. 2013: Delayed warfarin induced skin necrosis in a patient with poor warfarin metabolizing activity due to interrupted warfarin therapy European Journal of Clinical Pharmacology 69(2): 293-294
2011: I recently had complicated retina surgery and was taken off warfarin for five days prior to the operation. After the surgery, I was back on warfarin that evening. A few days later a blood clot reached the right side of my brain and I have been left with some numbness and coldness on my left side. Is there is a more conservative alternative to completely coming off warfarin? Heart advisor 14(4): 12
Lazo-Langner, A.; Monkman, K.; Kovacs, M.J. 2009: Predicting warfarin maintenance dose in patients with venous thromboembolism based on the response to a standardized warfarin initiation nomogram Journal of Thrombosis and Haemostasis: Jth 7(8): 1276-1283
Rondon, A.J.; Goswami, K.; Tan, T.L.; Shohat, N.; Parvizi, J. 2018: Majority of Total Joint Arthroplasties Are Subtherapeutic on Warfarin at time of Discharge: Another Reason to Avoid Warfarin as a Venous Thromboembolism Prophylaxis? Journal of Arthroplasty 33(9): 2787-2791
Said, A.; Keasberry, J. 2016: Ovarian malignancy unmasked by venous gangrene in a patient on warfarin therapy: a case report Journal of Medical Case Reports 10(1): 151
Cheng, S.; Flora, D.R.; Rettie, A.E.; Brundage, R.C.; Tracy, T.S. 2022: Pharmacokinetic Modeling of Warfarin Іi - Model-based Analysis of Warfarin Metabolites following Warfarin Administered either Alone or Together with Fluconazole or Rifampin Drug Metabolism and Disposition: the Biological Fate of Chemicals 2022
Chang, M.; Söderberg, M.M.; Scordo, M.G.; Tybring, G.; Dahl, M.-L. 2015: CYP2C19*17 affects R-warfarin plasma clearance and warfarin INR/dose ratio in patients on stable warfarin maintenance therapy European Journal of Clinical Pharmacology 71(4): 433-439
Hewick, D.S. 1972: The plasma half-lives of the enantiomers of warfarin in warfarin-resistant and warfarin-susceptible rats Journal of Pharmacy and Pharmacology 24(8): 661-662